Chavassieux P, Meunier P J
INSERM unité 403, Faculté Alexis Carrel, Lyon.
Rev Prat. 1995 May 1;45(9):1083-8.
Aging and menopause are the two main determinants of osteoporosis, a rarifying osteopathy due to bone loss. Type I osteoporosis observed in post-menopausal women is characterized mainly by trabecular bone loss results from an unbalanced coupling between resorption and formation inducing a thinning of trabeculae and from an increased osteoclast activation resulting in irreversible trabecular perforation. Anti-osteoclastic drugs prevent trabecular and cortical bone loss. Drugs that stimulate osteoblastic proliferation thicken trabecular plates but do not restore the normal trabecular microarchitecture after complete destruction of a large number of trabeculae. In type II osteoporosis, cortical bone loss is favoured by secondary hyperparathyroidism and is responsible for hip fracture. Calcium and vitamin D supplementations decrease the risk of hip fractures by reducing the secondary hyperparathyroidism.
衰老和绝经是骨质疏松症的两个主要决定因素,骨质疏松症是一种因骨质流失导致的骨质稀疏性骨病。绝经后女性中观察到的I型骨质疏松症主要特征是小梁骨丢失,这是由于吸收与形成之间的耦合失衡导致小梁变薄,以及破骨细胞活化增加导致不可逆的小梁穿孔。抗破骨细胞药物可预防小梁骨和皮质骨丢失。刺激成骨细胞增殖的药物可使小梁板增厚,但在大量小梁完全破坏后无法恢复正常的小梁微结构。在II型骨质疏松症中,继发性甲状旁腺功能亢进会加重皮质骨丢失,并导致髋部骨折。补充钙和维生素D可通过减轻继发性甲状旁腺功能亢进降低髋部骨折风险。